Telix Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Telix Pharmaceuticals stock have an average target of 21.13, with a low estimate of 20 and a high estimate of 22.5. The average target predicts an increase of 102.39% from the current stock price of 10.44.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$21.13	$22	$22.5
Change	+91.57%	+102.39%	+110.73%	+115.52%

Analyst Ratings

The average analyst rating for Telix Pharmaceuticals stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Nierengarten Wedbush	Wedbush	Buy Reiterates $22	Buy	Reiterates	$22	+110.73%	Apr 13, 2026
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+91.57%	Apr 13, 2026
David Nierengarten Wedbush	Wedbush	Buy Reiterates $22	Buy	Reiterates	$22	+110.73%	Apr 7, 2026
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+91.57%	Apr 7, 2026
Laura Sutcliffe Citigroup	Citigroup	Strong Buy Maintains $22 → $23	Strong Buy	Maintains	$22 → $23	+115.52%	Feb 24, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.